Form D — Evommune, Inc.
0002044725-25-000001 · filed Jan 7, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Other filings
Offering
- Industry
- Other
- Exemptions
- Rule 506(b)
- Reported offering amount
- $12,462,474
- Reported amount sold
- $12,462,474
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Evommune, Inc.
- CIK
- 2044725
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2020
- Address
- 1841 PAGE MILL RD
PALO ALTO, California 94304 - Phone
- (650) 223-7745
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Luis Pena · Executive OfficerPalo Alto, California Find on LinkedIn ↗
-
Eugene Bauer · Executive OfficerPalo Alto, California Find on LinkedIn ↗
-
Robert Hopfner · DirectorPalo Alto, California Find on LinkedIn ↗
-
Yuexin Yu · DirectorPalo Alto, California Find on LinkedIn ↗
-
Felice Verduyn-van Weegen · DirectorPalo Alto, California Find on LinkedIn ↗
-
Derek DiRocco · DirectorPalo Alto, California Find on LinkedIn ↗
-
Francois Beaubien · DirectorPalo Alto, California Find on LinkedIn ↗
-
Benjamin McGraw · DirectorPalo Alto, California Find on LinkedIn ↗
-
David Cohen · DirectorPalo Alto, California Find on LinkedIn ↗
-
Kyle Carver · Executive OfficerPalo Alto, California Find on LinkedIn ↗
-
Gregory Moss · Executive OfficerPalo Alto, California Find on LinkedIn ↗
-
Jeegar Patel · Executive OfficerPalo Alto, California Find on LinkedIn ↗
-
Janice Drew · Executive OfficerPalo Alto, California Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗